And we would get that from Gilead, Apple or Tesla?
Post# of 148168
(Total Views: 629)
Posted On: 07/13/2020 12:25:59 PM
And we would get that from Gilead, Apple or Tesla? That feels like and over reach.
Lots of frustration, I understand.
Let them do their jobs. We did not bring leronlimab to this point, Pourhassan et al did.
Read More: https://investorshangout.com/post/view?id=582...z6S5lC8HqH
______________________________
I don't care about Gilead, Apple or Tesla. This is up to their shareholders to decide. I began serious buying last December 21 when Nader swore on the Proactive that the remaining portions of the BLA would be submitted "in 9 days." And ever since then I had that vague nagging feeling that not everything was right with this BLA. I had it again when last week Nader said the PDUFA "could" come on the 10th. We are talking about much more than the BLA. It's about "your credibility, Sir" as British barristers used to put it. And btw, this is not only about ourselves and our families. It's our duty to hundreds thousands if not millions of people whose health and very lives may depend on the approval of leronlimab.
Lots of frustration, I understand.
Let them do their jobs. We did not bring leronlimab to this point, Pourhassan et al did.
Read More: https://investorshangout.com/post/view?id=582...z6S5lC8HqH
______________________________
I don't care about Gilead, Apple or Tesla. This is up to their shareholders to decide. I began serious buying last December 21 when Nader swore on the Proactive that the remaining portions of the BLA would be submitted "in 9 days." And ever since then I had that vague nagging feeling that not everything was right with this BLA. I had it again when last week Nader said the PDUFA "could" come on the 10th. We are talking about much more than the BLA. It's about "your credibility, Sir" as British barristers used to put it. And btw, this is not only about ourselves and our families. It's our duty to hundreds thousands if not millions of people whose health and very lives may depend on the approval of leronlimab.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼